Arkansas Study Links Medical Marijuana to Reduced Antiemetic Overuse in Cancer
A recent Arkansas study found that medical marijuana chemotherapy nausea cardholders were less likely to experience antiemetic overuse during cancer treatment. The study analyzed over 20,000 cancer patients and showed a 24% reduction in excessive…
How Pharmacogenomics Genetic Variants Influence GLP-1 Therapy
Pharmacogenomics genetic variants play a key role in modulating response to GLP-1 receptor agonists. These variants can affect both weight loss efficacy and side effect profiles, especially nausea with tirzepatide. Understanding these genetic factors…
What Works—and What Doesn’t—When CVS and CHS Attacks Strike at Home or in the ER
This 2025 clinical review details abortive therapy cyclic vomiting syndrome home ER approaches, synthesizing pharmacologic and non-pharmacologic strategies. It highlights the importance of early intervention during the prodromal phase for CVS and CHS…
Expert Guidance on Treating Cyclic Vomiting and Cannabis Hyperemesis Episodes at Home and in the ER
Acute abortive treatment cyclic vomiting syndrome is crucial for managing episodes early. Patients often experience a prodrome phase, allowing timely intervention. Effective abortive therapies can reduce episode severity and emergency visits.
Managing Cyclic Vomiting and Cannabis Hyperemesis Attacks: What the Evidence Says About Home and ER Treatment
Abortive therapy cyclic vomiting syndrome is critical for managing CVS and CHS attacks effectively. Early intervention during the prodrome phase can reduce episode severity. This approach supports home and emergency department treatment strategies.
Cannabis Hyperemesis Syndrome: A Psychiatric Approach
Cannabis hyperemesis syndrome psychiatric risk is a critical consideration in patients with chronic cannabis use presenting with cyclical vomiting. This syndrome often poses diagnostic challenges in psychiatric settings due to overlapping symptoms. Early…